SUNPHARMA.NS or VRTX: which has stronger momentum now?
As of 2026-09-01: SUNPHARMA.NS LONG (235 bars, uPnL +16.0%, total return +8.4%) vs VRTX LONG (72 bars, uPnL +20.8%, total return +9.2%). Momentum is the fourth gate — quality and valuation ceilings come first.
| Snapshot | 2026-09-01 · source: yahoo-direct | |
|---|---|---|
| SUNPHARMA.NS (Sun Pharmaceutical) | VRTX (Vertex) | |
| Market / sector | in · Pharma | us · Healthcare |
| Price | ₹1,913 | $547.29 |
| Quality score | —/100 | 100/100 |
| Engine signal | LONG · 235 bars · uPnL +16.0% | LONG · 72 bars · uPnL +20.8% |
| Total return | +8.4% | +9.2% |
Cite this page
Balance Labs Research Desk (2026-09-01). "SUNPHARMA.NS or VRTX: which has stronger momentum now?." balancelabs.app · https://balancelabs.app/stocks/compare/sunpharma.ns-vs-vrtx/q/sunpharma.ns-or-vrtx-stronger-momentum · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← SUNPHARMA.NS vs VRTX · snapshot 2026-09-01 · not investment advice